9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 24

Gender: All

Min Age: 20 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Phase1: Assessment of safety of BBI608 given in combination with Pemetrexed and Cisplatin by reporting the adverse events and serious adverse events.,  Phase1: Assessment of dose-limiting toxicities (DLTs).,  Phase1: Pharmacokinetics profile of BBI608 when administered with pemetrexed and cisplatin., Phase2: Progression Free Survival (PFS)

Interventions: BBI608, Pemetrexed

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: May 31, 2018

Completion Date: May 31, 2018

Last  Posted Date: November 7, 2018

Location: National Cancer Center Hospital East, Chiba, Japan

Website Link: https://ClinicalTrials.gov/show/NCT02347917

Was this article helpful?
Dislike 0